Run-in | Budesonide 3 mg | Budesonide 9 mg | Prednisolone 7.5 mg | Placebo | |
---|---|---|---|---|---|
Evaluable patients | 142 | 37 | 35 | 39 | 31 |
Exposure (days) | 2872 | 2681 | 3255 | 2312 | |
Number of adverse reactions (AE) | 91 | 94 | 97 | 88 | 70 |
Number of patients with serious adverse reactions | 2 | 0 | 2 | 2 | |
Number (%) of patients with AE | 89 (63%) | 33 (89%) | 33 (94%) | 33 (85%) | 28 (90%) |